News Nevro Corp.

Equities

NVRO

US64157F1030

Market Closed - Nyse Other stock markets 04:00:01 2024-04-17 pm EDT			5-day change	1st Jan Change
12.29 ^USD	-3.23%		-7.45%	-42.89%

Apr. 15	RBC Lowers Price Target on Nevro to $16 From $18, Keeps Sector Perform Rating	MT
Apr. 11	Mizuho Adjusts Price Target on Nevro to $16 From $20, Maintains Neutral Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024	Apr. 17	PR
RBC Lowers Price Target on Nevro to $16 From $18, Keeps Sector Perform Rating	Apr. 15	MT
Mizuho Adjusts Price Target on Nevro to $16 From $20, Maintains Neutral Rating	Apr. 11	MT
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off	Apr. 09	AQ
Citigroup Cuts Price Target on Nevro to $16 From $18, Maintains Neutral Rating	Apr. 03	MT
Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw	Feb. 28	PR
Nevro 2024 Sales Expected Slightly Below Estimates, RBC Says	Feb. 22	MT
Wells Fargo Adjusts Price Target on Nevro to $17 From $20, Maintains Equal-Weight Rating	Feb. 22	MT
Baird Cuts Price Target on Nevro to $19 From $23, Maintains Neutral Rating	Feb. 22	MT
Oppenheimer Downgrades Nevro to Perform From Outperform, Removes $35 Price Target	Feb. 22	MT
RBC Lowers Price Target on Nevro to $18 From $20, Keeps Sector Perform Rating	Feb. 22	MT
Earnings Flash (NVRO) NEVRO Posts Q4 Revenue $116.2M, vs. Street Est of $116M	Feb. 21	MT
Engaged Capital Enters into Agreement with Nevro Corp	Feb. 21	CI
Transcript : Nevro Corp., Q4 2023 Earnings Call, Feb 21, 2024	Feb. 21
Nevro: Q4 Earnings Snapshot	Feb. 21	AQ
Nevro Enters Into Cooperation Agreement With Engaged Capital	Feb. 21	PR
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results	Feb. 21	PR
Nevro Corp. Appoints Kirt P. Karros to Board of Directors and Audit Committee of the Board	Feb. 21	CI
Nevro Corp. Provides Earnings Guidance for the First Quarter and Full Year of 2024	Feb. 21	CI
Nevro Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nevro Corp.

Equities

NVRO

US64157F1030

Summary

Filters